Grant: CIHR Fellowship
Direct Payment
$150,000.00
Molecular Signatures in the First Episode Psychosis
FY 2013-14
Summary
Recent research on psychotic disorders such as schizophrenia (SZ) supports a model wherein aberrant brain changes in late adolescence contribute to the onset and early progression of the diseases. To further examine this model, longitudinal studies of genetically high-risk subjects and patients with recent-onset SZ or related disorders are growing in number. However, most of these studies limit their focus to clinical or neuropsychological characterization, or to brain imaging alone. As a result, the molecular mechanisms underlying these dynamic changes remain elusive. The discovery of new molecular signatures and biomarkers of these illnesses becomes essential for a better understanding of psychotic disorders. This project is part of an extensive, longitudinal and multidisciplinary research program and aims to recruit patients at the outset of, or within the first few years after the onset of any disease with psychotic features, hereafter referred to as a first episode psychosis (FEP), in order to get a clear picture of the neuropsychological, genetic, molecular and electrophysiological aspects of the FEP. More precisely, we want to identify new molecular targets and genetic variants associated with the FEP by conducting a comprehensive molecular study on multiple tissues biopsies and an estimation of the concentration of several molecules associated with psychotic disorders by magnetic resonance spectroscopy. Finally, we want to determine if the genetic/molecular alterations observed in the FEP are correlated with the clinical aspects of the FEP. Our findings will be essential to identify other molecular pathways implicated in the pathophysiology of psychotic disorders as well as to develop novel therapeutic strategies for mental illnesses.
Department
Program
CIHR Fellowship
Recipient
Location
Maryland, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
300532
Name
Lavoie Joëlle
Region
Maryland
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Fellowships - Post-PhD
Projecttitle
Molecular Signatures in the First Episode Psychosis
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Biomarkers; First Episode Psychosis; Gaba; Glutamate; Magnetic Resonance Spectroscopy; Molecular Target; Psychotic Disorders; Risk Factor; Schizophrenia
Abstract
Recent research on psychotic disorders such as schizophrenia (SZ) supports a model wherein aberrant brain changes in late adolescence contribute to the onset and early progression of the diseases. To further examine this model, longitudinal studies of genetically high-risk subjects and patients with recent-onset SZ or related disorders are growing in number. However, most of these studies limit their focus to clinical or neuropsychological characterization, or to brain imaging alone. As a result, the molecular mechanisms underlying these dynamic changes remain elusive. The discovery of new molecular signatures and biomarkers of these illnesses becomes essential for a better understanding of psychotic disorders. This project is part of an extensive, longitudinal and multidisciplinary research program and aims to recruit patients at the outset of, or within the first few years after the onset of any disease with psychotic features, hereafter referred to as a first episode psychosis (FEP), in order to get a clear picture of the neuropsychological, genetic, molecular and electrophysiological aspects of the FEP. More precisely, we want to identify new molecular targets and genetic variants associated with the FEP by conducting a comprehensive molecular study on multiple tissues biopsies and an estimation of the concentration of several molecules associated with psychotic disorders by magnetic resonance spectroscopy. Finally, we want to determine if the genetic/molecular alterations observed in the FEP are correlated with the clinical aspects of the FEP. Our findings will be essential to identify other molecular pathways implicated in the pathophysiology of psychotic disorders as well as to develop novel therapeutic strategies for mental illnesses.
Competitiondate
201311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lavoie, Joëlle
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~